|

CD33KO-HSPC; CART33 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Pennsylvania1

Indications

  • Leukemia, Myeloid, Acute1
  • Cancer1

Philadelphia, Pennsylvania1 trial

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

University of Pennsylvania

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.